SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 149 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 4.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $1,408,000 | -66.4% | 119,300 | -68.7% | 0.00% | -70.0% |
Q1 2017 | $4,196,000 | -17.5% | 381,439 | +1.6% | 0.01% | -16.7% |
Q4 2016 | $5,087,000 | +311.6% | 375,463 | +274.0% | 0.01% | +300.0% |
Q3 2016 | $1,236,000 | -44.6% | 100,390 | -50.7% | 0.00% | -40.0% |
Q2 2016 | $2,232,000 | -5.8% | 203,487 | -6.1% | 0.01% | -16.7% |
Q1 2016 | $2,370,000 | +0.4% | 216,821 | +58.8% | 0.01% | +20.0% |
Q4 2015 | $2,361,000 | +5.0% | 136,534 | +20.6% | 0.01% | 0.0% |
Q3 2015 | $2,249,000 | +7.0% | 113,168 | -11.5% | 0.01% | +25.0% |
Q2 2015 | $2,101,000 | +4.7% | 127,899 | -0.8% | 0.00% | 0.0% |
Q1 2015 | $2,007,000 | -73.8% | 128,942 | -76.0% | 0.00% | -75.0% |
Q4 2014 | $7,661,000 | +52.4% | 536,548 | -30.6% | 0.02% | +45.5% |
Q3 2014 | $5,027,000 | -6.2% | 773,386 | -0.4% | 0.01% | -8.3% |
Q2 2014 | $5,359,000 | -6.1% | 776,724 | -2.7% | 0.01% | -7.7% |
Q1 2014 | $5,708,000 | +123.8% | 798,341 | +194.3% | 0.01% | +116.7% |
Q4 2013 | $2,550,000 | – | 271,239 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 1,304,376 | $23,414,000 | 7.30% |
Kassirer Asset Management Corp | 291,784 | $5,238,000 | 5.39% |
First Trust Capital Management L.P. | 637,578 | $11,445,000 | 2.19% |
NEXTHERA CAPITAL LP | 510,486 | $9,163,000 | 1.69% |
HAVENS ADVISORS LLC | 100,000 | $1,795,000 | 1.35% |
Piermont Capital Management Inc. | 172,980 | $3,105,000 | 1.02% |
PRELUDE CAPITAL MANAGEMENT, LLC | 674,446 | $12,106,000 | 0.97% |
ALPINE ASSOCIATES MANAGEMENT INC. | 1,495,600 | $26,845,000 | 0.96% |
LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 200,000 | $3,590,000 | 0.87% |
BOOTHBAY FUND MANAGEMENT, LLC | 332,075 | $5,961,000 | 0.87% |